Cautiously Bullish After Biohaven's Cash Runway And Dilution Risk Rise [Seeking Alpha]
Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN)
Last biohaven pharmaceutical holding company ltd. common shares earnings: 2/25 04:45 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.biohavenpharma.com
Company Research
Source: Seeking Alpha
BHVN's pipeline remains diverse, but key assets like Opakalim for depression and Taldefgrobep alfa for SMA missed primary endpoints. Current cash runway is approximately 3.1 quarters, heightening urgency for successful near-term clinical milestones and FDA approvals. In my view, the bull thesis now hinges on BHV-1400 (IgAN), BHV-1300 (Graves), Opakalim (focal epilepsy), plus taldefgrobep alfa (obesity/SMA). BHVN also remains pre-revenue and has a somewhat tight runway at this point. I can't ignore these setbacks, which is why I am downgrading the stock to a “Buy.”. Guido Mieth/DigitalVision via Getty Images Biohaven Ltd. ( BHVN ) is a clinical-stage biopharmaceutical company with a broad pipeline focused on neuroscience, immunology, muscle and metabolism, and oncology. Their Phase 2 depression trial for Opakalim (BHV-7000) reported that their candidate failed to meet its primary endpoint. As a result, BHVN discontinued its psychiatric research This article was written by
Show less
Read more
Impact Snapshot
Event Time:
BHVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHVN alerts
High impacting Biohaven Pharmaceutical Holding Company Ltd. Common Shares news events
Weekly update
A roundup of the hottest topics
BHVN
News
- Nvidia, Micron, Nike, Tesla, Biohaven, Coupang, and More Stock Market Movers [Barron's]Barrons
- Biohaven defended despite depression trial setback [Seeking Alpha]Seeking Alpha
- Biohaven (NYSE:BHVN) had its "market perform" rating reaffirmed by analysts at William Blair.MarketBeat
- Biohaven (NYSE:BHVN) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Biohaven (NYSE:BHVN) had its "neutral" rating reaffirmed by analysts at HC Wainwright.MarketBeat
BHVN
Earnings
- 11/10/25 - Beat
BHVN
Sec Filings
- 11/18/25 - Form 4
- 11/17/25 - Form 4
- 11/17/25 - Form 4
- BHVN's page on the SEC website